Menu

Agenda

Wednesday, March 20, 2019

12:00 pm Registration
12:00 pmExhibitor Set-Up
CORPORATE SPONSORED EDUCATIONAL SYMPOSIA
1:00 – 6:00 pmCorporate Sponsored Educational Symposia

Thursday, March 21, 2019

6:30 – 7:00 am Breakfast / Coffee
General Session
7:00 – 7:15 amWelcome Remarks & Sponsor Acknowledgements
  • Shalom Kalnicki, MD, President of the RSS Board of Directors
7:15 – 7:45 amKeynote Address: Value-Based Medicine in the Current Healthcare Economic Environment
  • Brian D. Kavanagh, MD, MPH, FASTRO, University of Colorado, Aurora, CO
Clinical Session
7:50 – 10:00 amSession I Clinical Abstract Presentations with Q&A
  • Central Nervous System Session: Part 1
    Clinical Abstract Presentations with Q&A
    7:50 - 7:59 amInteractions between Dose, Cavity Size, and Histology in the Prediction of Local Control following Stereotactic Radiosurgery for Resected Brain Metastases
    Chengcheng Gui, BSE, Johns Hopkins University School of Medicine, Baltimore, MD
    8:00 - 8:09 amTumor Control and Survival in Patients with Ten or More Brain Metastases Treated with Stereotactic Radiosurgery: A Retrospective Analysis
    Matthew Ehrlich, BS, Northwell Health, Hempstead, NY
    8:10 - 8:19 amManagement of Brain Metastases from Large Cell Neuroendocrine Carcinoma of the Lung: Improved Outcomes with Radiosurgery
    Shaakir Hasan, DO, Allegheny Health Network, Pittsburgh, PA
    8:20 - 8:29 amHigh-Grade Toxicity after Combination Radiosurgery Anti-PD-1 Immunotherapy for Brain Metastases
    Roman Travis, BS, The University of Alabama at Birmingham School of Medicine, Birmingham, AL
    8:30 - 8:39 amDosimetric Comparison of Protons versus Photons for Treatment of Pituitary Adenoma
    Shivani Sud, MD, Massachusetts General Hospital, Boston, MA
    8:40 - 8:49 amPrimary and Repeat Linac Radiosurgery for Cerebral Arteriovenous Malformations in Pediatric Population
    Slawomir Blamek, MD, PhD, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
    8:50 - 9:00 amQ&A - CNS Session: Part 1
  • Central Nervous System Session: Part 2
    Clinical Abstract Presentations with Q&A
    9:00 - 9:09 amSystemic Therapy as a Risk Factor Associated to Complications in SBRT for Spine Metastases
    Christian Arias, MD, Centre Hospitalier De L'Université De Montréal, Montréal, Quebec, Canada
    9:10 - 9:19 amInitial Observation of Vestibular Schwannomas: A Modern Institutional Experience
    Aditya Patibandla, BS, Mayo Clinic, Rochester, MN
    9:20 - 9:29 amClinic Feasibility of Frameless Functional Radiosurgery with a Virtual Cone
    John Fiveash, MD, University Alabama at Birmingham Hospital, Birmingham, AL
    9:30 - 9:39 amThe Dancing Cord: Inherent Spinal Cord Motion and Its effect on Cord Dose in Spine Stereotactic Body Radiation Therapy
    Murat Alp Oztek, MD, University of Washington Medical Center, Seattle, WA
    9:40 - 9:49 amTherapeutic Effect of Fractionated CyberKnife Radiosurgery for High Volume Huge Cavernous Sinus Cavernous Hemangioma
    Lichao Huang, MD, PLA General Hospital, Beijing, China
    9:50 - 10:00 amQ&A - CNS Session: Part 2
10:00 – 10:30 amCoffee Break / Visit with Exhibitors
10:30 am – 12:00 pmSession II Clinical Abstract Presentations with Q&A
  • SRS/SBRT for Clinical Applications
    Clinical Abstract Presentations with Q&A
    10:30 - 10:39 amDose-Response Modeling the Risk of Carotid Bleeding Events after Stereotactic Body Radiation Therapy for Previously-Irradiated Head and Neck Cancer
    Diane C. Ling, MD, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA
    10:40 - 10:49 amUnconventional SBRT-Based Partial Irradiation of Unresectable Bulky Tumors exploiting the Bystander and Abscopal Effects
    Slavisa Tubin, MD, KABEG Klinikum Klagenfurt, Klagenfurt, Austria
    10:50 - 10:59 amTrends of Stereotactic Body Radiation Therapy Utilization in the United States from 2004-2015
    Eric Lehrer, MD, MS, Northwell Health - Mather Hospital, Port Jefferson, NY
    11:00 - 11:09 amLong-Term Results of Stereotactic Thermal Destruction Drug-Resistant Temporal Lobe Epilepsy
    Elena Slobina, MD, PhD, Russian Scientific Center of Roentgenoradiology, Moscow, Russia
    11:10 - 11:20 amQ&A - Other Categories Session
  • Thoracic Session
    Clinical Abstract Presentations with Q&A
    11:20 - 11:29 amClinical Outcomes following Stereotactic Body Radiation Therapy (SBRT) for Small-Cell Lung Carcinoma: A Preliminary Analysis from The RSSearch® Patient Registry
    Raj Singh, MD, Virginia Commonwealth University, Richmond, VA (1); Mather Hospital, Port Jefferson, NY (2)
    11:30 - 11:39 amStereotactic Body Radiotherapy for Pulmonary Non-Small Cell Neuroendocrine Tumors
    Anand Mahadevan, MD, Geisinger Cancer Institute- Geisinger Health, Danville, PA
    11:40 - 11:49 amEarly Feasibility Study for Cardiac Radiosurgery: Evaluation of Novel 3-D Treatment Planning Software and Safety Data on First Three Patients
    Brad Pollard, MS, Austin CyberKnife, Austin, TX
    11:50 am - 12:00 pmQ&A - Thoracic Session
12:00 – 1:30 pmLunch & Exhibit Hall Presentations
1:30 – 4:00 pmSession III Clinical Abstract Presentations with Q&A
  • Genitourinary Session
    Clinical Abstract Presentations with Q&A
    1:30 - 1:39 pmTen-Year Final Results of the TROG 03.04 (Radar) Randomised Phase 3 Trial with an Analysis of the Relative Benefit of Radiation Dose Escalation and Longer Hormone Duration to Prevent Distant Progression with Locally Advanced Prostate Cancer
    David Joseph, MD, MBBS, FRANZCR, MRACMA, 5D Clinics, Perth, WA, Australia
    1:40 - 1:49 pmTen-Year Final Results of the TROG 03.04 (Radar) Randomised Phase 3 Trial evaluating Duration of Androgen Suppression ± Zoledronate for Locally Advanced Prostate Cancer
    David Joseph, MD, MBBS, FRANZCR, MRACMA, 5D Clinics, Perth, WA, Australia
    1:50 - 1:59 pmOutcomes of Stereotactic Body Radiotherapy delivered by Gantry-Based Linear Accelerators for Low- and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Study
    Audrey Dang, MD, UCLA, Los Angeles, CA
    2:00 - 2:09 pmImplications for Appropriate Margins in Radiosurgery of Bone Oligometastases from Prostate Cancer: An Analysis of Sodium Flouride (NaF) PET/CT Response Assessment in the POPSTAR Clinical Trial
    Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia
    2:10 - 2:19 pmContinence and Voiding Outcomes after Stereotactic Body Radiation in Prostate Cancer Patients with Prior Trans Urethral Resection of Prostate
    Lee McNeely, MD, Anova Cancer Care, Lone Tree, CO
    2:20 - 2:29 pmUtilization of Stereotactic Body Radiation Therapy for Localized Prostate Cancer at Georgetown University Hospital: An Analysis of Patient Demographics and Travel Distance
    Nima Aghdam, MD, Georgetown University Hospital, Washington, DC
    2:30 - 2:45 pmQ&A - Genitourinary Session
  • Gastrointestinal Session
    Clinical Abstract Presentations with Q&A
    2:45 - 2:54 pmStereotactic Body Radiotherapy (SBRT) for Colorectal Liver Metastasis - Clinical Outcomes from the International Multi-Institutional RSSearch® Patient Registry
    Pollyanna Leite, MD, Guy's Hospital, London, UK
    2:55 - 3:04 pmAdjuvant Pancreatic SBRT for Close or Positive Margins
    Philip Sutera, BS, UPMC Hillman Cancer Center, Pittsburgh, PA
    3:05 - 3:14 pmStereotactic Body Radiation Therapy with Immunotherapy in the Treatment of Oligometastatic Disease: A Subset Analysis of a Prospective Phase II Trial
    Philip Sutera, BS, UPMC Hillman Cancer Center, Pittsburgh, PA
    3:15 - 3:24 pmPrognostic Factors for SBRT in Pancreatic Cancer: Analysis of the Multi-Institutional RSSearch® Patient Registry Database
    Amanda Rivera, MD, Montefiore Medical Park, Bronx, NY
    3:25 - 3:34 pmReal-Time Magnetic Resonance Guided Liver Stereotactic Body Radiation Therapy
    Aharon Feldman, MD, Henry Ford Health System, Detroit, MI
    3:35 - 3:44 pmLiver Function Abnormalities Twelve Months after Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC)
    Justin Tang, MD, Montefiore Medical Park, Bronx, NY
    3:45 - 4:00 pmQ&A - Gastrointestinal Session
4:00 – 4:30 pmAfternoon Break
PHYSICS Session
8:00 – 10:00 am
  • Physics Abstract Presentations with Q&A: Part 1
    8:00 - 8:14 amReal-Time Target Tracking in Pancreatic SBRT: Characterizing the Clinical Impact
    Bernard Jones, PhD, University of Colorado, Denver, CO
    8:15 - 8:29 amDetermination of Treatment Margins for Head and Neck Tumors Treated with a Robotic Radiosurgery System using Spine or Skull Tracking
    Justin Hurley, University of Louisville Brown Cancer Center, Louisville, KY
    8:30 - 8:44 amDose Discrepancy of External SRS Audit - Investigation of Linac Deliverability Factors
    Kirsty Blythe, PhD, Guy's and St Thomas NHS Foundation Trust, London, UK
    8:45 - 8:59 amDetermining the Spatial Accuracy of Frameless Linac-Based Radiosurgery for Trigeminal Neuralgia
    Daphne Levin, PhD, Assuta Medical Centers, Tel Aviv, Israel
    9:00 - 9:14 amComparison of Surrogate Matching Methods for Target Localization with Free-Breathing in Stereotactic Body Radiation Treatment for Liver Tumors
    Shilby Paul, MD, PhD, Montefiore Medical Center, Bronx, NY
    9:15 - 9:29 amEvaluation of a Novel Streamlined Solution for MLC-Based Intracranial SRS
    Everardo Flores-Martinez, PhD, University of San Diego, San Diego, CA
    9:30 - 9:44 amSRS Quality Assurance Using Real-Time Optical Imaging
    Muhammad Ramish Ashraf, BS, Dartmouth College, Hanover, NH
    9:45 - 10:00 amTowards Application of Cone Beam CT Dosimetry (CBCT-D) to Multifocal SRS End-to-End Testing
    Justus Adamson, PhD, Duke University, Durham, NC
10:00 – 10:30 amCoffee Break / Visit with Exhibitors
10:30 am – 12:00 pm
  • Physics Abstract Presentations with Q&A: Part 2
    10:30 - 10:44 amPlan Quality Control for Single Isocenter Multiple Target Radiosurgery with a Knowledge-Based Optimization Model
    Yun Yang, PhD, Duke University, Durham, NC
    10:45 - 10:59 amProfile Comparisons of Small Dose Volumes between Three Radiosurgery Systems
    Steve Sorensen, PhD, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ
    11:00 - 11:14 amA Comparison of Intracranial Gross Tumor Volumes Generated on MPRAGE and VIBE MR Protocols
    Amelia Wexler, MS, University of Missouri, Columbia, MO
    11:15 - 11:29 amDose Discrepancy of External UK SRS Audit - Investigation of Planning Factors
    Kirsty Blythe, PhD, Guy's and St Thomas NHS Foundation Trust, London, UK
    11:30 - 11:44 amMonte Carlo Commissioning for CyberKnife Multileaf Collimator and Proposed Acceptance Criteria
    Tatsiana Reynolds, PhD, Minnesota Oncology, Minneapolis, MN
    11:45 am - 12:00 pmA Beam Applicator for Radiosurgery of the Eye using a Scanning Ion Beam Delivery System
    Michael Moyers, PhD, Shanghai Proton and Heavy Ion Center, Shanghai, China
12:00 – 1:30 pmLunch & Exhibit Hall Presentations/Visit with Exhibitors
1:30 – 2:45 pm

Artificial Intelligence and Quantitative Analysis Perspective on Radiation Oncology and SRS/SBRT Session

Moderators:

  • Stanley H. Benedict, PhD, FAAPM, University of California, Davis, Davis, CA
  • Timothy D. Solberg, PhD, FACR, FACMP, FAAPM, FASTRO, University of California, San Francisco, San Francisco, CA
  • Fang-Fang Yin, PhD, Duke University, Durham, NC

Current and future Artificial Intelligence in Radiation Oncology and SRS/SBRT
Jackie Wu, PhD, Duke University, NC

The Future of Quantitative Imaging in Radiation Oncology and SRS/SBRT
Olivier Morin, PhD, University of California, San Francisco, CA

2:45 – 4:00 pm

Quality Assurance as It Relates to Various Treatment Systems

Moderators:

  • Grace Kim, PhD, University of California, San Diego, San Diego, CA
  • Christoph Fürweger, PhD, European CyberKnife Center, Munich, Germany

Quality Assurance for MR-Guided Radiosurgery
James Balter, PhD, University of Michigan, Ann Arbor, MI

The Benefits of Monte Carlo-Based Secondary Dose Calculation in a Comprehensive QA Solution
Markus Alber, PhD, Heidelberg University, Heidelberg, Germany

IROC’s External Quality Assurance Audits for Radiosurgery
Stephen F. Kry, PhD, MD Anderson Cancer Center, Houston, TX

4:00 – 4:30 pmAfternoon Break/Visit with Exhibitors
General Session
4:30 – 5:45 pm
  • Tumor Control Probability Guidelines for SRS/SBRT

    As an evolving treatment modality in both the primary and recurrent setting, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) is increasingly being used worldwide. It is well-recognized that the radiobiology of radiosurgery and its associated outcomes for a variety of tumor types remains a “works-in-progress.” In the Tumor Control Probability Guidelines” session, we will present the “state of the science” by recognized experts in the field of lung, head & neck and spine.

Moderator:

  • Dwight E. Heron, MD, MBA, FACRO, FACR, UPMC Hillman Cancer Center, Pittsburgh, PA

Overview of Tumor Control Probability Guidelines
Jimm Grimm, PhD, Johns Hopkins Medical Center, Baltimore MD

SABR/SBRT for Lung - Tumor Probability Guidelines
Percy P. Lee, MD, David Geffen School of Medicine, UCLA; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA

Radiosurgery for Spine - Tumor Probability Guidelines
Scott Soltys, MD, Stanford University Medical Center, Stanford, CA

SABR/SBRT for Head & Neck - Tumor Probability Guidelines
Andy Clump, MD, PhD, UPMC Hillman Cancer Center, Pittsburgh, PA

5:45 – 6:00 pmBEST CLINICAL ABSTRACT - Stereotactic Body Radiation Therapy for Early Stage Breast Cancer using a Robotic Linear Accelerator-5 Year Results from the NYU Winthrop Hospital Trial
Jonathan Haas, MD, NYU Winthrop Hospital, Mineola, NY
6:00 – 6:15 pmBEST PHYSICS ABSTRACT - The Lessons of QUANTEC Reproduced in HyTEC
Jimm Grimm, PhD, Johns Hopkins University, Baltimore, MD
MARCH MADNESS MIX & MINGLE EVENT
6:15 – 8:00 pm

“March Madness” Reception

  • Mix and Mingle Evening Event
  • Poster Presentations
  • Walk With A Professor Poster Walk
  • Award Presentations

Friday, March 22, 2019

7:00 – 7:30 amLight Breakfast / Coffee
General Session
7:00 – 9:00 am

Current and Future Approaches to Combining Immunotherapy & Radiosurgery

A joint session hosted by the Radiosurgery Society (the RSS) in collaboration with the Society for Immunotherapy of Cancer (SITC).

Session Chairs:

  • Mansoor M. Ahmed, PhD, National Cancer Institute/National Institutes of Health, Rockville, MD
  • Marka Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

Opening Remarks
Mansoor M. Ahmed, PhD, National Cancer Institute/National Institute of Health, Rockville, MD

Cancer Immunology / Immunotherapy: A Primer for Radiation Oncologists & Medical Physicists
Alice O. Kamphorst, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Opportunities and Challenges of Combining SBRT and Immunotherapy
Stephen L. Shiao, MD, PhD, Cedars-Sinai Medical Center and University of California, Los Angeles, Los Angeles, CA

Combining Interleukin-2 and SBRT for Melanoma
Marka R. Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

FLT3 Ligand and SBRT for Lung Cancer
Chandan Guha, MBBS, PhD, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Combination Immunotherapy and SBRT for Head & Neck Cancer
Nadeem Riaz, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Closing Remarks
Marka R. Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

9:00 – 10:15 am
  • Recent Developments in SRS for Functional Diseases

    Brain science continues to evolve and along with it so must diagnoses and treatment options. Optimizing patient care by combining clinical and technological breakthroughs; incorporating artificial intelligence and brain-fusion techniques; and collaboration with innovation are critical to advancing functional neurological treatment breakthroughs. This session will highlight the advancements in the treatment of Parkinson’s Disease, Epilepsy, Trigeminal Neuralgia, Obsessive Compulsive Disorders and Essential Tremors using Stereotactic Radiosurgery from a few of the world’s leading neurosurgeons.

Moderators:

  • Michael Schulder, MD, FAANS, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
  • Pantaleo Romanelli, MD, CyberKnife Center, CDI, Milano, Italy

SRS for Obsessive Compulsive Disorder
David Mathieu, MD, FRCS(C), Université de Sherbrooke, Sherbrooke, Qc, Canada

SRS for Parkinson’s and Epilepsy
Sameer Seth, MD, PhD, Baylor College of Medicine, TX

SRS for Trigeminal Neuralgia
Konstantin V. Slavin, MD, University of Illinois at Chicago, Chicago, IL

SRS vs Focused Ultrasound
Casey Halpern, MD, Stanford University Medical Center, Stanford, CA

10:15 – 10:45 amCoffee Break/Visit with Exhibitors
10:45 – 12:00 pm
  • Building Collaborative Teams – Exchanging Experiences and Addressing Challenges

    This interactive session will give attendees direct access to those who have survived (and thrived) the growing-pains of building successful SRS/SBRT programs. Topics will include administrative strategic growth, incorporating academic research processes, utilizing the RSSearch patient registry, economic program development, cultivating a harmonious multi-disciplinary culture and how to navigate the introduction of new technologies and programs.

    Attendees will be given the opportunity throughout the session to present questions and experiences faced within their own institutions to be addressed by a panel of experts of all specialties.

Moderator:

  • Brian D. Kavanagh, MD, MPH, FASTRO, University of Colorado, Aurora, CO

Session Chairs:

  • Iris Gibbs, MD, Stanford Medical Center
  • Shalom Kalnicki, MD, Montefiore Medical Center/Albert Einstein College of Medicine
  • Simon Lo, MD, University of Washington
  • Susan Pannullo, MD, FAANS, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
  • Michael Schulder, MD, FAANS, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY

Expert Panelists:

  • Iris Gibbs, MD, and Laurie Tupper, NP-C, AOCNP, Stanford Medical Center
  • Dwight Heron, MD, and Annette Quinn, RT, UPMC Hillman Cancer Centers
  • Shalom Kalnicki, MD, Montefiore Medical Center/Albert Einstein College of Medicine
  • Simon Lo, MD, University of Washington
  • Anand Mahadevan, MD, Geisinger Health System
  • Susan Pannullo, MD, FAANS, and Jonathan Knisely, MD, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
  • Michael Schulder, MD, FAANS, and Anuj Goenka, MD, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
12:00 – 1:30 pmLunch & Presentations in Exhibit Hall
MARCH MADNESS SHOWDOWN DEBATES
1:30 – 1:45 pmShowdown Debate Opening Remarks
1:45 – 3:00 pm

Debate I: SRS vs Whole Brain Radiation Therapy for Brain Metastases - Is SRS a Slam Dunk for Brain Metastases?

Presented by:

  • Hany Soliman, MD, FRCPC, Assistant Professor, University of Toronto, Toronto, Canada
  • Mark V. Mishra, MD, University of Maryland Medical System, Baltimore, MD
3:00 – 4:15 pm

Debate II: SBRT vs Focal Ablation Therapy for Primary Renal Cell Carcinoma – Let the Madness Begin

Presented by:

  • Robert Abouassaly, MD, Cleveland Clinic, Cleveland, OH
  • Shankar Siva, PhD, MBBS, FRANZCR, Sir Peter MacCullum Cancer Center, Melbourne, Australia
4:15 – 4:45 pmCoffee Break/Visit with Exhibitors
AFTERNOON BREAKOUT SESSIONS
4:45 – 6:00 pm

Concurrent Sessions:

  • RSSearch® Patient Registry Breakout
  • Residents’ Breakout
EVENING ON OWN

Saturday, March 23, 2019

7:30 – 8:30 amBreakfast
General Session
8:00 – 10:00 am

Performance & Quality Improvement Session (PQIS) with Case-Based Discussions

Individual case presentations based on submissions.

Moderators:

  • Richard D. Bucholz, MD, FACS, St. Louis University Hospital Medical Center, St. Louis, MO
  • John J. Kresl, MD, PhD, DABR, FACR, FACRO, Phoenix CyberKnife & Radiation Oncology Center, Phoenix, AZ

This session is restricted – no guest, commercial vendors, exhibitor or staff will be allowed into the room.

The Powerpoint presentation template may be downloaded here.

10:00 – 10:30 amCoffee Break/Visit with Exhibitors
10:30 am – Noon

Dosimetry Plan Study – SBRT for Pancreatic Cancer

Announcement and presentations of top performing submitted cases.

A joint session hosted by the Radiosurgery Society (the RSS) in collaboration with the American Association of Medical Dosimetrists (AAPM)

Session Chair:

  • Anand Mahadevan, MD, Geisinger Medical Center, Danville, PA

Expert Panelists:

  • Steve Burton, MD, UPMC Hillman Cancer Center, Pittsburg, PA
  • Daniel Chang, MD, Stanford University Medical Center, Stanford, CA
  • Amol Narang, MD, Johns Hopkins Medicine, Baltimore, MD
  • Brian Wang, PhD, University of Louisville, Louisville, KY
  • Grace Kim, PhD, University of San Diego, San Diego, CA

Individual Case Presentations based on Submissions

Noon – 1:00 pmLunch/Visit with Exhibitors/RSS Annual Meeting
1:00 – 2:30 pm

Didactic Session (no charge to attend)

  • Lung SABR/SBRT Workshop: Current Challenges and Future Directions

    The RSS will be holding a special lecture series and hands-on workshop focused on the current challenges of lung stereotactic body radiotherapy (SBRT) treatment planning and delivery, the conundrum of post SBRT follow up imaging and recommended practices and updates from the clinical trials on SBRT for early-stage operable lung cancer. The session will also explore single fraction radiosurgery for thoracic tumors and future indications for lung SBRT. The lecture series will be open to all registered 2019 RSS Scientific Meeting attendees. The Hands-On Workshop will be held immediately after the lecture series and will focus on clinical case discussions, contouring, treatment planning tips and tricks by the expert panel and demonstrations by various Corporate Vendors. There is an additional registration fee for the Hands-On Workshop and limited attendance.

Session Chairs:

  • Drew Moghanaki, MD, Atlanta Veterans Affairs Healthcare Systems, Emory University School of Medicine, Decatur, GA
  • Ben J. Slotman, MD, PhD, FACR, VU University Medical Center, Amsterdam, Netherlands

SABR for Operable Stage I NSCLC: Lessons Learned from the VALOR Trial
Drew Moghanaki, MD, Atlanta Veterans Affairs Healthcare Systems, Emory University School of Medicine, Decatur, GA

Evolving Paradigms for Lung SBRT
Pam Samson, MD, Washington University, St. Louis, MO

The Conundrum of Post-SBRT Thoracic Imaging
Ben J. Slotman, MD, PhD, FACR, VU University Medical Center, Amsterdam, Netherlands

SBRT for Metastatic Lung Cancer
Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia

2:30 – 4:30 pm

Lung SABR/SBRT Hands-On Workshop*

Moderator:

  • Brian Wang, PhD, University of Louisville, Louisville, KY

Common Mistakes with Lung SBRT: Lessons from LUSTRE
Anand Swaminath, MD, MacMaster University, Hamilton, Canada

Vendor Station Rotations and Presentations:
Clinical cases, treatment planning tips and tricks, and pearls and pitfalls. Attendees will have 20-minute rotations to learn and interact with Corporate Vendors and Expert Panelists.

Expert Panelists:

  • Pam Samson, MD, Washington University, St. Louis, MO
  • Anand Swaminath, MD, McMaster University, Hamilton, Canada
  • Drew Moghanaki, MD, Atlanta Veterans Affairs Healthcare Systems, Emory University School of Medicine, Decatur, GA
  • Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia

* There is an additional registration fee to attend this hands-on workshop.

RSS Members: $55.00
Non-RSS Members: $85.00

4:30 pmMeeting Adjourns

Session Descriptions

Tumor Control Probability Guidelines for SRS/SBRT
As an evolving treatment modality in both the primary and recurrent setting, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) is increasingly being used worldwide. It is well-recognized that the radiobiology of radiosurgery and its associated outcomes for a variety of tumor types remains a “works-in-progress.” In the Tumor Control Probability Guidelines” session, we will present the “state of the science” by recognized experts in the field of lung, head & neck and spine.

Recent Developments in SRS for Functional Diseases
Brain science continues to evolve and along with it so must diagnoses and treatment options. Optimizing patient care by combining clinical and technological breakthroughs; incorporating artificial intelligence and brain-fusion techniques; and collaboration with innovation are critical to advancing functional neurological treatment breakthroughs. This session will highlight the advancements in the treatment of Parkinson’s Disease, Epilepsy, Trigeminal Neuralgia, Obsessive Compulsive Disorders and Essential Tremors using Stereotactic Radiosurgery from a few of the world’s leading neurosurgeons.

Building Collaborative Teams – Exchanging Experiences and Addressing Challenges
This interactive session will give attendees direct access to those who have survived (and thrived) the growing-pains of building successful SRS/SBRT programs. Topics will include administrative strategic growth, incorporating academic research processes, utilizing the RSSearch patient registry, economic program development, cultivating a harmonious multi-disciplinary culture and how to navigate the introduction of new technologies and programs.

Attendees will be given the opportunity throughout the session to present questions and experiences faced within their own institutions to be addressed by a panel of experts of all specialties.

Lung SABR/SBRT: Current Challenges and Future Directions Workshop
The RSS will be holding a special lecture series and hands-on workshop focused on the current challenges of lung stereotactic body radiotherapy (SBRT) treatment planning and delivery, the conundrum of post SBRT follow up imaging and recommended practices and updates from the clinical trials on SBRT for early-stage operable lung cancer. The session will also explore single fraction radiosurgery for thoracic tumors and future indications for lung SBRT. The lecture series will be open to all registered 2019 RSS Scientific Meeting attendees. The Hands-On Workshop will be held immediately after the lecture series and will focus on clinical case discussions, contouring, treatment planning tips and tricks by the expert panel and demonstrations by various Corporate Vendors. There is an additional registration fee for the Hands-On Workshop and limited attendance.

For event questions, email rssevents@therss.org